Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 18, 2012
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - Market Wire
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
[ Thu, Oct 18th 2012
] - WOPRAI
Christopher Raymond Maintained (BIIB) at Buy with Increased Target to $179 on, Oct 18th, 2012
Christopher Raymond of Piper Sandler, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $159 to $179 on, Oct 18th, 2012.
Christopher has made no other calls on BIIB in the last 4 months.
There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jay Olson of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, October 4th, 2012
These are the ratings of the 4 analyists that currently disagree with Christopher
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012
- Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $160 on, Thursday, September 6th, 2012
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, July 25th, 2012
- Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012
